Navigation Links
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
Date:8/25/2013

with the United States Securities and Exchange Commission (the "SEC") by Amgen and a Solicitation/Recommendation Statement on Schedule 14D-9 will be filed with the SEC by Onyx. The offer to purchase shares of Onyx common stock will only be made pursuant to the offer to purchase, the letter of transmittal and related documents filed as a part of the Schedule TO. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ BOTH THE TENDER OFFER STATEMENT AND THE SOLICITATION/RECOMMENDATION STATEMENT REGARDING THE OFFER, AS THEY MAY BE AMENDED FROM TIME TO TIME, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. The tender offer statement will be filed with the SEC by Amgen and Arena Acquisition Company, a wholly owned subsidiary of Amgen, and the solicitation/recommendation statement will be filed with the SEC by Onyx. Investors and security holders may obtain a free copy of these statements (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the Information Agent for the tender offer which will be named in the tender offer statement.

1 Revlimid® is a registered trademark of Celgene Corporation.
2 Velcade® is a registered trademark of Millennium Pharmaceuticals, Inc.

Contact:Amgen
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

Onyx
Lori Melancon, 650-266-2394 (media)
Amy Figueroa, 650-266-2398 (investors)

(Logo: http://photos.prnewswire.com/prnh/20130825/LA69117LOGO)
(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... MILL VALLEY, Calif. , Sept. 17, 2014 ... a partnership in the fight against sarcoma. Under ... Alliance Suzanne Renee Leider Memorial Assistance Fund. ... to reimburse sarcoma patients for expenses directly related ... specialist. Scientific literature reinforces the importance of this ...
(Date:9/17/2014)... Sept. 17, 2014  Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that agreement has been reached with the ... design of a pivotal, Phase 3 clinical trial ... treatment of cutaneous T-cell lymphoma (CTCL).  ...
(Date:9/16/2014)... Massachusetts , 17. September 2014 ... HOLX ), hat heute die ... zur präanalytischen Probenverarbeitung, in Europa bekannt ... gekennzeichnete, vollautomatisierte Universalplattform zur Vereinfachung der ... dass ineffiziente und fehlerbehaftete Arbeitsschritte bei ...
Breaking Medicine Technology:Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 2Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 3Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 4Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 5Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 6Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 7Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3
... Inspiration Biopharmaceuticals, Inc. (Inspiration), the only ... of new treatment options for people with hemophilia, is ... as Chief Executive Officer. Mr. Butler replaces Michael Griffith, ... Officer and is retaining the title of President at ...
... 11, 2011 Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ... financial results on Tuesday, October 25, 2011 after the close ... conference call and slide presentation via webcast on Tuesday, October ... to discuss results and highlights of the third quarter, as ...
Cached Medicine Technology:Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer 2Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer 3Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011 2
(Date:9/17/2014)... sip of a perfectly poured glass of wine leads to ... University, Denmark, have now developed a nanosensor that can mimic ... sensor measures how you experience the sensation of dryness in ... wine, they need to control a number of processes to ... up in the wine bottle. An important part of the ...
(Date:9/17/2014)... U.S. News and World Report ... and three mesothelioma treatment centers made the magazine’s ... law firm Baron and Budd reports. ... Texas MD Anderson Cancer Center and Brigham and ... http://health.usnews.com/best-hospitals/rankings/cancer ) , U.S. News and World Report ...
(Date:9/17/2014)... 17, 2014 Tina Griffin, a Senior Sales ... her chemotherapy but not her fight against cancer. Though weakened ... Florida Suncoast “Race for the Cure” on Saturday, Oct. 11, ... Komen Race for the Cure because I wanted to make ... , As part of her efforts, she is asking those ...
(Date:9/17/2014)... Wailea, Maui, HI (PRWEB) September 17, 2014 ... has announced the eighth annual Wailea Tennis Fantasy ... 19-23, 2014 at Maui’s prestigious Wailea Tennis Club, with ... ranked Lindsay Davenport returning to Wailea, Maui for her ... world-class instruction and match play with Davenport, recently inducted ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A raucous ... Disease come together to form author Nancy Chovancek’s laughter-filled ... book is a collection of short stories that prove ... on fun. With a positive message of empowerment and ... Chovancek is a proven author with two books under ...
Breaking Medicine News(10 mins):Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Tina Griffin’s Fight Against Cancer Didn’t Stop With her Chemotherapy—Her Next Step Is to Run in the Suncoast ‘Race for the Cure’ Oct. 11 2Health News:Four Seasons Resort Maui at Wailea Announces 8th Annual Wailea Tennis Fantasy Camp 2Health News:Four Seasons Resort Maui at Wailea Announces 8th Annual Wailea Tennis Fantasy Camp 3
... hospitality service portfolio, SHAWNEE, Kan., Dec. 5 ... the healthcare industry, will change its name to ... the new brand is the,expanded service portfolio and ... satisfaction., Avascend currently provides the following core ...
... MISSISSAUGA, ON, Dec. 5 /PRNewswire-FirstCall/ - Cipher Pharmaceuticals,Inc. ... M.D., CFA, has been,appointed to its Board of ... years of experience in the global,healthcare industry. He ... Alpharma, Inc. (NYSE: ALO ), a leading ...
... 5 Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: ... recognized for its leading scientific and pharmaceutical,achievements at ... London,England on December 4. Wyeth received honors for ... are given out by Scrip World Pharmaceutical News,a ...
... bones of their children far more often than moms, and ... than five months old, according to a study in Child ... one study case, a child suffered 31 broken or fractured ... other abusive injuries, including burns, abrasions, bruises or head trauma. ...
... gene involved in communication among brain cells has a direct ... study by scientists supported by the National Institute on Alcohol ... Health (NIH), and the U.S. Army. , Scientists do not ... effect on alcohol consumption, exists in humans. , Known ...
... decrease by 45%, ATLANTA, Dec. 5 ... its ED Patient Flow initiative to,dramatically improve performance. ... a 50% reduction in radiology turnaround time for ... "Various,performance improvement teams working on specific parts of ...
Cached Medicine News:Health News:AVP is Now Avascend 2Health News:Cipher appoints Stefan Aigner to board of directors 2Health News:Cipher appoints Stefan Aigner to board of directors 3Health News:Wyeth Receives Honors at the 2007 Scrip Awards 2Health News:Wyeth Receives Honors at the 2007 Scrip Awards 3Health News:Wyeth Receives Honors at the 2007 Scrip Awards 4Health News:Wyeth Receives Honors at the 2007 Scrip Awards 5Health News:Dads break bones of children more often than moms 2Health News:Scientists identify gene that influences alcohol consumption 2Health News:SciHealth Inc. Helps Mary Washington Hospital Improve Emergency Department Performance 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: